| Relationship of established risk factors with breast cancer subtypes AM McCarthy, T Friebel‐Klingner, S Ehsan, W He, M Welch, J Chen, ... Cancer medicine 10 (18), 6456-6467, 2021 | 90 | 2021 |
| Performance of breast cancer risk-assessment models in a large mammography cohort AM McCarthy, Z Guan, M Welch, ME Griffin, DA Sippo, Z Deng, ... JNCI: Journal of the National Cancer Institute 112 (5), 489-497, 2020 | 78 | 2020 |
| High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing CA Lissandrello, JA Santos, P Hsi, M Welch, VL Mott, ES Kim, J Chesin, ... Scientific reports 10 (1), 18045, 2020 | 55 | 2020 |
| Breastfeeding indicators among a nationally representative multi-ethnic sample of New Zealand children T Gontijo de Castro, C Grant, C Wall, M Welch, E Marks, C Fleming, ... New Zealand Medical Association, 2017 | 52 | 2017 |
| Uncovering mutation-specific morphogenic phenotypes and paracrine-mediated vessel dysfunction in a biomimetic vascularized mammary duct platform ML Kutys, WJ Polacheck, MK Welch, KA Gagnon, T Koorman, S Kim, L Li, ... Nature communications 11 (1), 3377, 2020 | 40 | 2020 |
| Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer AM McCarthy, NP Kumar, W He, S Regan, M Welch, B Moy, AJ Iafrate, ... BMC cancer 20 (1), 1-10, 2020 | 15 | 2020 |
| Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19 C Cloer, L Roudsari, L Rochelle, T Petrie, M Welch, J Charest, K Tan, ... Plos one 16 (11), e0259732, 2021 | 10 | 2021 |
| Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram AM McCarthy, S Ehsan, S Appel, M Welch, W He, M Bahl, J Chen, ... Cancer 127 (18), 3334-3342, 2021 | 10 | 2021 |
| A platform to reproducibly evaluate human colon permeability and damage EE Marr, TJ Mulhern, M Welch, P Keegan, C Caballero-Franco, ... Scientific Reports 13 (1), 8922, 2023 | 9 | 2023 |
| High‐Throughput CRISPR/Cas9 Mediated Gene Editing of Primary Human T Cells in a Microfluidic Device for Cellular Therapy Manufacturing M Welch, DA Flusberg, P Hsi, NJ Haroutunian, JA Santos, ES Kim, ... Advanced Materials Technologies, 2300275, 2023 | 5 | 2023 |
| Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer AM McCarthy, AK Manning, S Hsu, M Welch, B Moy, CD Lehman, ... Breast Cancer Research and Treatment 196 (2), 389-398, 2022 | 2 | 2022 |
| Breastfeeding duration among a nationally representative multi-ethnic sample of New Zealand children T Gontijo de Castro, C Grant, C Wall, M Welch, E Marks, CJ Fleming, ... Paediatric Society of New Zealand 68th Annual Scientific Meeting 2016, 2016 | 1 | 2016 |
| Sa137 A HIGH-THROUGHPUT MICROPHYSICOLOGIC SYSTEM ACCURATELY MODELS HUMAN COLON AND ILEUM FUNCTIONS E Marr, TJ Mulhern, BC Hoefler, M Welch, C Caballero-Franco, ... Gastroenterology 160 (6), S-433-S-434, 2021 | | 2021 |
| Abstract PS7-02: The relationship of established breast cancer risk factors with breast cancer subtypes AM McCarthy, T Friebel, W He, M Welch, S Ehsan, K Hughes, A Semine, ... Cancer Research 81 (4_Supplement), PS7-02-PS7-02, 2021 | | 2021 |
| Misclassification of reported exclusive breastfeeding duration within the Growing up in New Zealand cohort. T Gontijo de Castro, C Grant, CR Wall, M Welch, JA Teixeira, E Marks, ... 15th World Congress on Public Health, 2017 | | 2017 |
